Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 04/28/26
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ETGlobeNewsWire • 04/24/26
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target?Zacks Investment Research • 04/20/26
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New GenericsZacks Investment Research • 04/20/26
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT ExclusivityGlobeNewsWire • 04/20/26
How Much Upside is Left in ANI (ANIP)? Wall Street Analysts Think 41.71%Zacks Investment Research • 04/17/26
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release CapsulesGlobeNewsWire • 04/13/26
ANI Pharmaceuticals Looks Undervalued As Cortrophin Drives Rare Disease GrowthSeeking Alpha • 04/10/26
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate TabletGlobeNewsWire • 04/08/26
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in OphthalmologyGlobeNewsWire • 04/07/26
Can ANI (ANIP) Climb 43.86% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 04/01/26
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare DiseaseZacks Investment Research • 03/31/26